Results 191 to 200 of about 48,929 (237)
Some of the next articles are maybe not open access.

Association between LDL/HDL ratio and in-stent restenosis in patients with acute coronary syndrome after stent implantation.

Biomarkers in Medicine, 2022
Background: The relationship between LDL/HDL ratio and in-stent restenosis in acute coronary syndrome is unknown. Methods: This observational study recruited 256 patients with acute coronary syndrome who were being followed up by angiography after ...
Yang Fang   +4 more
semanticscholar   +1 more source

Paclitaxel-Coated Balloon vs Uncoated Balloon for Coronary In-Stent Restenosis: The AGENT IDE Randomized Clinical Trial.

Journal of the American Medical Association (JAMA)
Importance Drug-coated balloons offer a potentially beneficial treatment strategy for the management of coronary in-stent restenosis. However, none have been previously evaluated or approved for use in coronary circulation in the United States ...
Robert W. Yeh   +64 more
semanticscholar   +1 more source

In-stent restenosis

The Journal of Cardiovascular Surgery
Endovascular arterial recanalization has become the mainstay therapy for peripheral arterial occlusive disease. Although immediate technical success is achieved in greater than 90% of cases, longer-term results continue to vary based on the clinical presentation, and the treated target lesion.
El Khoury, Rym   +5 more
openaire   +3 more sources

Precision Management of Coronary In-Stent Restenosis.

Trends in cardiovascular medicine
The advent of percutaneous coronary intervention (PCI) and intracoronary stent development marked a pivotal milestone in the management of acute coronary syndromes, significantly reducing morbidity and mortality worldwide.
Travis M Wilson   +11 more
semanticscholar   +1 more source

In-stent restenosis in vertebral artery stenting

Neuroradiology, 2007
Sir, Tsutsumi et al. reported the clinical and angiographic data on 12 patients receiving stent deployment for symptomatic ostial vertebral artery (VA) stenosis [1]. The in-stent re-stenosis (ISR) rate was surprising low – 0% angiographic restenosis at 12 months and 8% after a mean of 31.5 months clinical/radiological follow-up.
Yen-Hung, Lin, Hsien-Li, Kao
openaire   +2 more sources

Recurrent drug eluting stent, in-stent restenosis (DES-ISR): Epidemiology, pathophysiology & treatment.

Progress in cardiovascular diseases
Coronary artery in-stent restenosis (ISR) is driven by neointimal hyperplasia and neoatherosclerosis in previously placed stents. Drug eluting stents (DES) have been adopted as first line therapy for the initial episode of ISR. However, recurrent ISR has
Aashish Gupta   +2 more
semanticscholar   +1 more source

Waksman In-Stent Restenosis Classification: A mechanism-based approach to the treatment of restenosis.

Cardiovascular Revascularization Medicine, 2021
Despite contemporary advances in stent technology, in-stent restenosis (ISR) remains a common issue following percutaneous coronary intervention. A novel classification system based on underlying mechanism of action of restenosis was recently introduced.
Evan Shlofmitz   +7 more
semanticscholar   +1 more source

Debulking With Excimer Laser Coronary Angioplasty Versus Balloon Angioplasty in Patients With in Stent Restenosis (ELDISR Study): A Randomized Controlled Trial

Lasers in Surgery and Medicine
Excimer laser coronary angioplasty (ELCA) is a safe and effective method for lesion preparation. However, its impact on clinical outcomes in patients with in‐stent restenosis (ISR) undergoing drug‐coated balloon (DCB) angioplasty remains unclear.
Pan He   +6 more
semanticscholar   +1 more source

Drug-Coated Balloon Angioplasty vs Plain Balloon Angioplasty in Patients with Coronary In-Stent Restenosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Current problems in cardiology
BACKGROUND In-stent restenosis (ISR) remains a significant challenge in interventional cardiology despite advancements in stent technology. Drug-coated balloons (DCBs), which deliver antiproliferative agents directly to the vessel wall, have emerged as a
Michael Sabina   +5 more
semanticscholar   +1 more source

Excimer laser coronary angioplasty combined with drug‐coated balloon in the treatment of in‐stent restenosis

Lasers in Surgery and Medicine
The aim of this study is to investigate the safety and efficacy of excimer laser coronary angioplasty (ELCA) combined with drug‐coated balloons (DCBs) in the treatment of in‐stent restenosis (ISR), and to explore whether the contrast injection technique ...
Pan He   +6 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy